U.S. Supreme Court rules in favor of generic drug patents
(The Center Square) - The U.S. Supreme Court, in a unanimous decision on Thursday, ruled that a cardiovascular drugmaker did not violate America's patent laws. The ruling could allow for generic drug manufacturers to produce more without fear of patent lawsuits.
Justices on the high court ruled in